FRS2 and lung cancer: Seven of the twelve upregulated genes were verified, namely BRAF, CCNI, EGFR, FGF19, FRS2, GREB1, and LZTS1. These seven mRNA biomarkers show significant differences between the lung cancer and matched control groups (p < 0.05).